Systemic Anaplastic Large Cell Lymphoma Relapsed | Systemic Anaplastic Large Cell Lymphoma refractory | Status post Chemotherapeutics regimen first line of treatment
Item
patients with relapsed or refractory systemic alcl who have previously received front line chemotherapy.
boolean
C1336548 (UMLS CUI [1,1])
C0205336 (UMLS CUI [1,2])
C1336548 (UMLS CUI [2,1])
C0205269 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C2045825 (UMLS CUI [3,2])
Anaplastic lymphoma kinase Status Documented
Item
documented anaplastic lymphoma kinase (alk) status.
boolean
C0252409 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C1301725 (UMLS CUI [1,3])
Disease CD30 positive | Tissue specimen Biopsy Recurrent disease | Tissue specimen Biopsy Refractory Disease | CD30 expression Slide | CD30 expression Tumor Block
Item
histologically-confirmed cd30-positive disease; tissue from the most recent post diagnostic biopsy of relapsed/refractory disease must be available for confirmation of cd30 expression via slides or tumor block.
boolean
C0012634 (UMLS CUI [1,1])
C3888910 (UMLS CUI [1,2])
C1292533 (UMLS CUI [2,1])
C0005558 (UMLS CUI [2,2])
C0277556 (UMLS CUI [2,3])
C1292533 (UMLS CUI [3,1])
C0005558 (UMLS CUI [3,2])
C1514815 (UMLS CUI [3,3])
C3888510 (UMLS CUI [4,1])
C1705201 (UMLS CUI [4,2])
C3888510 (UMLS CUI [5,1])
C0027651 (UMLS CUI [5,2])
C1533157 (UMLS CUI [5,3])
Fluorodeoxyglucose F18 Avidity PET | Measurable Disease Size PET | Fluorodeoxyglucose F18 Avidity Spiral CT | Measurable Disease Size Spiral CT
Item
fluorodeoxyglucose-avid and measurable disease of at least 1.5 cm as documented by both positron emission tomography and spiral computed tomography.
boolean
C0046056 (UMLS CUI [1,1])
C1510996 (UMLS CUI [1,2])
C0032743 (UMLS CUI [1,3])
C1513041 (UMLS CUI [2,1])
C0456389 (UMLS CUI [2,2])
C0032743 (UMLS CUI [2,3])
C0046056 (UMLS CUI [3,1])
C1510996 (UMLS CUI [3,2])
C0860888 (UMLS CUI [3,3])
C1513041 (UMLS CUI [4,1])
C0456389 (UMLS CUI [4,2])
C0860888 (UMLS CUI [4,3])
Autologous hematopoietic stem cell transplant
Item
received any previous autologous stem cell transplant at least 12 weeks (3 months) prior.
boolean
C2193200 (UMLS CUI [1])
Age | Geographic Location
Item
at us sites, patients greater than or equal to 12 years of age may be enrolled. at non-us sites, patients must be greater than or equal to 18 years of age.
boolean
C0001779 (UMLS CUI [1])
C0017446 (UMLS CUI [2])
brentuximab vedotin
Item
previous treatment with brentuximab vedotin.
boolean
C2973446 (UMLS CUI [1])
Transplantation, Homologous
Item
previously received an allogeneic transplant.
boolean
C0040739 (UMLS CUI [1])
Primary Cutaneous Anaplastic Large Cell Lymphoma | Patients Transformed Systemic Anaplastic Large Cell Lymphoma Eligible
Item
patients with current diagnosis of primary cutaneous alcl (patients who have transformed to systemic alcl are eligible).
boolean
C1301362 (UMLS CUI [1])
C0030705 (UMLS CUI [2,1])
C0457344 (UMLS CUI [2,2])
C1336548 (UMLS CUI [2,3])
C1548635 (UMLS CUI [2,4])
Cerebral disorder | Meningeal disorder
Item
known cerebral/meningeal disease.
boolean
C0234387 (UMLS CUI [1])
C0154728 (UMLS CUI [2])